Anemia, Hemolytic, Congenital - 19 Studies Found

Enrolling by invitation : Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
:
  • Beta-Thalassemia
  • Sickle Cell Disease

: 2015-11-30
: Other: Safety and efficacy assessments Vector copy number (VCN) measurement, safety evaluations, disease
Completed : Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies
:
  • Sickle Cell Disease
  • Thalassemia

: 2015-01-21
: Biological: CordIn CordIn™ is a cryopreserved stem/progenitor cell-based product of purified CD133
Completed : HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
:
  • Sickle Cell Disease
  • Beta Thalassemia-Major

: 2015-04-24
:
  • Drug: alemtuzumab (Campath IH)

Completed : Sickle Cell Hemoglobinopathies and Bone Health
:
  • Sickle Cell Disease
  • Sickle Cell Trait

: 2014-12-01
:
  • Other: Healthy volunteers without SCT

Completed : Non-Myeloablative Conditioning and Bone Marrow Transplantation
:
  • Sickle Cell Disease
  • Hemoglobinopathies

: 2013-05-01
:
  • Drug: Thymoglobulin

Terminated : Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic Diseases
: Anemia, Sickle Cell
: 2009-02-09
:
  • Procedure: Skin biopsy
  • Procedure: Blood dr
Suspended : Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
:
  • Anemia, Sickle Cell
  • Complex and Transfusion-dependent Hemoglobinopathies
  • Hereditary Elliptocytosis (HE)
  • Hereditary Pyropoikilocytosis (HPP)

: 2008-07-24
Recruiting : Screening for Subjects to Participate in Studies of Blood Disorders
:
  • Bone Marrow Transplant
  • Sickle Cell Disease
  • G-CSF
    • : 2008-06-07
<<< Previous